Guided Therapeutics, Inc. (GTHP)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.66 Million USD | -50.42% |
| 2022 | 3.36 Million USD | 65.0% |
| 2021 | 2.04 Million USD | 51.11% |
| 2020 | 1.35 Million USD | 14.41% |
| 2019 | 1.18 Million USD | 400.0% |
| 2018 | 236 Thousand USD | -51.74% |
| 2017 | 489 Thousand USD | -67.23% |
| 2016 | 1.49 Million USD | -41.79% |
| 2015 | 2.56 Million USD | -15.44% |
| 2014 | 3.03 Million USD | -8.59% |
| 2013 | 3.31 Million USD | -4.66% |
| 2012 | 3.47 Million USD | -19.3% |
| 2011 | 4.31 Million USD | 9.98% |
| 2010 | 3.91 Million USD | 396.7% |
| 2009 | 789 Thousand USD | -9.83% |
| 2008 | 875 Thousand USD | -10.44% |
| 2007 | 977 Thousand USD | -21.27% |
| 2006 | 1.24 Million USD | -29.09% |
| 2005 | 1.75 Million USD | -37.61% |
| 2004 | 2.8 Million USD | -58.22% |
| 2003 | 6.71 Million USD | -10.14% |
| 2002 | 7.47 Million USD | -59.23% |
| 2001 | 18.32 Million USD | 156.37% |
| 2000 | 7.14 Million USD | -7.17% |
| 1999 | 7.7 Million USD | 0.0% |
| 1998 | 7.7 Million USD | -48.67% |
| 1997 | 15 Million USD | 154.24% |
| 1996 | 5.9 Million USD | 686.67% |
| 1995 | 750 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.49 Million USD | -10.49% |
| 2024 Q2 | 1.25 Million USD | -16.27% |
| 2023 FY | 1.66 Million USD | -50.42% |
| 2023 Q1 | 2.89 Million USD | -14.08% |
| 2023 Q2 | 2.34 Million USD | -18.81% |
| 2023 Q3 | 1.87 Million USD | -20.06% |
| 2023 Q4 | 1.66 Million USD | -11.08% |
| 2022 Q1 | 2.18 Million USD | 7.21% |
| 2022 FY | 3.36 Million USD | 65.0% |
| 2022 Q2 | 1.5 Million USD | -31.28% |
| 2022 Q3 | 3.87 Million USD | 157.55% |
| 2022 Q4 | 3.36 Million USD | -13.05% |
| 2021 Q2 | 2.06 Million USD | -12.49% |
| 2021 Q1 | 2.36 Million USD | 74.96% |
| 2021 Q3 | 1.74 Million USD | -15.63% |
| 2021 FY | 2.04 Million USD | 51.11% |
| 2021 Q4 | 2.04 Million USD | 16.97% |
| 2020 FY | 1.35 Million USD | 14.41% |
| 2020 Q1 | 364 Thousand USD | -69.15% |
| 2020 Q2 | 942 Thousand USD | 158.79% |
| 2020 Q3 | 1.3 Million USD | 38.0% |
| 2020 Q4 | 1.35 Million USD | 3.85% |
| 2019 Q1 | 404 Thousand USD | 71.19% |
| 2019 Q4 | 1.18 Million USD | 248.08% |
| 2019 Q3 | 339 Thousand USD | 30.38% |
| 2019 Q2 | 260 Thousand USD | -35.64% |
| 2019 FY | 1.18 Million USD | 400.0% |
| 2018 FY | 236 Thousand USD | -51.74% |
| 2018 Q3 | 491 Thousand USD | 17.46% |
| 2018 Q1 | 527 Thousand USD | 7.77% |
| 2018 Q2 | 418 Thousand USD | -20.68% |
| 2018 Q4 | 236 Thousand USD | -51.93% |
| 2017 Q4 | 489 Thousand USD | -45.97% |
| 2017 FY | 489 Thousand USD | -67.23% |
| 2017 Q2 | 1.5 Million USD | 1.07% |
| 2017 Q3 | 905 Thousand USD | -39.99% |
| 2017 Q1 | 1.49 Million USD | 0.0% |
| 2016 Q4 | 1.49 Million USD | -27.57% |
| 2016 Q2 | 2.31 Million USD | -2.24% |
| 2016 Q3 | 2.06 Million USD | -10.94% |
| 2016 FY | 1.49 Million USD | -41.79% |
| 2016 Q1 | 2.36 Million USD | -7.69% |
| 2015 Q1 | 2.56 Million USD | -15.54% |
| 2015 Q2 | 4.03 Million USD | 57.7% |
| 2015 Q3 | 2.76 Million USD | -31.46% |
| 2015 FY | 2.56 Million USD | -15.44% |
| 2015 Q4 | 2.56 Million USD | -7.37% |
| 2014 Q4 | 3.03 Million USD | -18.57% |
| 2014 FY | 3.03 Million USD | -8.59% |
| 2014 Q2 | 3.82 Million USD | 47.23% |
| 2014 Q1 | 2.59 Million USD | -21.71% |
| 2014 Q3 | 3.72 Million USD | -2.62% |
| 2013 Q2 | 4.39 Million USD | 22.62% |
| 2013 FY | 3.31 Million USD | -4.66% |
| 2013 Q3 | 2.93 Million USD | -33.33% |
| 2013 Q1 | 3.58 Million USD | 3.08% |
| 2013 Q4 | 3.31 Million USD | 13.14% |
| 2012 Q1 | 3.08 Million USD | -28.42% |
| 2012 Q2 | 3.51 Million USD | 14.04% |
| 2012 Q4 | 3.47 Million USD | -27.1% |
| 2012 FY | 3.47 Million USD | -19.3% |
| 2012 Q3 | 4.77 Million USD | 35.62% |
| 2011 FY | 4.31 Million USD | 9.98% |
| 2011 Q4 | 4.31 Million USD | 51.81% |
| 2011 Q3 | 2.83 Million USD | -14.44% |
| 2011 Q2 | 3.31 Million USD | 5.77% |
| 2011 Q1 | 3.13 Million USD | -19.95% |
| 2010 FY | 3.91 Million USD | 396.7% |
| 2010 Q4 | 3.91 Million USD | 14.42% |
| 2010 Q3 | 3.42 Million USD | 308.71% |
| 2010 Q1 | 625 Thousand USD | -20.79% |
| 2010 Q2 | 838 Thousand USD | 34.08% |
| 2009 Q4 | 789 Thousand USD | -43.03% |
| 2009 FY | 789 Thousand USD | -9.83% |
| 2009 Q1 | 742 Thousand USD | -15.2% |
| 2009 Q2 | 870 Thousand USD | 17.25% |
| 2009 Q3 | 1.38 Million USD | 59.2% |
| 2008 Q3 | 939 Thousand USD | -9.1% |
| 2008 Q4 | 875 Thousand USD | -6.82% |
| 2008 FY | 875 Thousand USD | -10.44% |
| 2008 Q2 | 1.03 Million USD | -23.31% |
| 2008 Q1 | 1.34 Million USD | 37.87% |
| 2007 Q3 | 1.43 Million USD | -30.6% |
| 2007 Q4 | 977 Thousand USD | -32.06% |
| 2007 Q1 | 2.18 Million USD | 76.23% |
| 2007 Q2 | 2.07 Million USD | -5.26% |
| 2007 FY | 977 Thousand USD | -21.27% |
| 2006 Q3 | 1.55 Million USD | -1.58% |
| 2006 FY | 1.24 Million USD | -29.09% |
| 2006 Q1 | 2.25 Million USD | 28.8% |
| 2006 Q2 | 1.58 Million USD | -29.72% |
| 2006 Q4 | 1.24 Million USD | -20.4% |
| 2005 FY | 1.75 Million USD | -37.61% |
| 2005 Q4 | 1.75 Million USD | 27.74% |
| 2005 Q3 | 1.37 Million USD | -43.94% |
| 2005 Q2 | 2.44 Million USD | 29.52% |
| 2005 Q1 | 1.88 Million USD | -32.73% |
| 2004 Q2 | 7.92 Million USD | -29.65% |
| 2004 Q3 | 6.24 Million USD | -21.18% |
| 2004 Q4 | 2.8 Million USD | -55.08% |
| 2004 Q1 | 11.26 Million USD | 67.72% |
| 2004 FY | 2.8 Million USD | -58.22% |
| 2003 Q3 | 6.15 Million USD | -9.83% |
| 2003 Q1 | 9.19 Million USD | 23.11% |
| 2003 FY | 6.71 Million USD | -10.14% |
| 2003 Q4 | 6.71 Million USD | 9.12% |
| 2003 Q2 | 6.82 Million USD | -25.82% |
| 2002 Q2 | 10.83 Million USD | -27.44% |
| 2002 Q3 | 9.53 Million USD | -11.96% |
| 2002 Q1 | 14.93 Million USD | -18.52% |
| 2002 Q4 | 7.47 Million USD | -21.66% |
| 2002 FY | 7.47 Million USD | -59.23% |
| 2001 Q2 | 14.97 Million USD | 232.83% |
| 2001 FY | 18.32 Million USD | 156.37% |
| 2001 Q4 | 18.32 Million USD | 44.11% |
| 2001 Q3 | 12.71 Million USD | -15.08% |
| 2001 Q1 | 4.49 Million USD | -37.06% |
| 2000 Q1 | 10.68 Million USD | 38.75% |
| 2000 FY | 7.14 Million USD | -7.17% |
| 2000 Q4 | 7.14 Million USD | 6.83% |
| 2000 Q3 | 6.69 Million USD | -25.99% |
| 2000 Q2 | 9.04 Million USD | -15.38% |
| 1999 Q4 | 7.7 Million USD | 108.11% |
| 1999 Q3 | 3.7 Million USD | 0.0% |
| 1999 Q2 | 3.7 Million USD | -40.32% |
| 1999 Q1 | 6.2 Million USD | -19.48% |
| 1999 FY | 7.7 Million USD | 0.0% |
| 1998 FY | 7.7 Million USD | -48.67% |
| 1998 Q1 | 13.4 Million USD | -10.67% |
| 1998 Q2 | 11.3 Million USD | -15.67% |
| 1998 Q3 | 9 Million USD | -20.35% |
| 1998 Q4 | 7.7 Million USD | -14.44% |
| 1997 FY | 15 Million USD | 154.24% |
| 1997 Q2 | 4.2 Million USD | -14.29% |
| 1997 Q4 | 15 Million USD | -9.09% |
| 1997 Q3 | 16.5 Million USD | 292.86% |
| 1997 Q1 | 4.9 Million USD | -17.65% |
| 1996 FY | 5.9 Million USD | 686.67% |
| 1996 Q4 | 5.95 Million USD | 0.0% |
| 1995 FY | 750 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 4.51% |
| BioElectronics Corporation | 144.38 Thousand USD | -1055.913% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | -67.067% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -91.669% |
| Polarean Imaging plc | 10.86 Million USD | 84.642% |
| AVITA Medical, Inc. | 144.33 Million USD | 98.844% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -428.165% |
| Össur hf. | 1.39 Billion USD | 99.88% |
| Zecotek Photonics Inc. | 2.57 Million USD | 35.131% |
| QHSLab, Inc. | 1.68 Million USD | 0.739% |
| Wellstar International, Inc. | 957.89 Thousand USD | -74.237% |
| Össur hf. | 1.39 Billion USD | 99.88% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 98.378% |
| Escalon Medical Corp. | 4.75 Million USD | 64.922% |
| Aurora Spine Corporation | 11.92 Million USD | 86.003% |
| BrainsWay Ltd. | 62.97 Million USD | 97.35% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 41.501% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 98.485% |
| Vivos Inc. | 1.61 Million USD | -3.657% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.958% |
| Kelyniam Global, Inc. | 1.63 Million USD | -2.224% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -38.355% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -2948.513% |
| Nanomix Corporation | 982.05 Thousand USD | -69.95% |
| Theraclion SA | 18.66 Million EUR | 91.057% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -816.127% |
| Positron Corporation | 1.76 Million USD | 5.581% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -123.014% |
| Lombard Medical, Inc. | 67.76 Million USD | 97.537% |
| ALR Technologies Inc. | 193.21 Thousand USD | -763.796% |
| Stratec SE | 529.71 Million USD | 99.685% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -68.195% |
| Heart Tronics, Inc. | 4.04 Million USD | 58.779% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 24.549% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 91.875% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 92.554% |
| VMS Rehab Systems, Inc. | 4.45 USD | -37505517.978% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -126.232% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -266.175% |
| United American Healthcare Corporation | 10.37 Million USD | 83.919% |
| ECGI Holdings, Inc. | 5.2 Million USD | 67.913% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -4838.747% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 21.963% |
| Urologix, Inc. | 5.66 Million USD | 70.549% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 25.973% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 91.799% |
| SS Innovations International, Inc. | 25.47 Million USD | 93.45% |
| Qualis Innovations, Inc. | 2431.00 USD | -68554.875% |
| Smith & Nephew plc | 9.97 Billion USD | 99.983% |
| NIOX Group Plc | 116.47 Million USD | 98.567% |
| Fuse Medical, Inc. | 16.25 Million USD | 89.735% |
| Broncus Holding Corporation | 195.75 Million USD | 99.147% |
| Brain Scientific Inc. | 11.74 Million USD | 85.788% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -59.001% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -5708.248% |